title: The medicinal chemistry of the P2 receptor family.
authors.affiliation: Department of Medicinal Chemistry, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, Leicestershire, LE11 5RH, UK.
authors.forename: S D
authors.initials: SD
authors.lastname: Guile
authors.forename: F
authors.initials: F
authors.lastname: Ince
authors.forename: A H
authors.initials: AH
authors.lastname: Ingall
authors.forename: N D
authors.initials: ND
authors.lastname: Kindon
authors.forename: P
authors.initials: P
authors.lastname: Meghani
authors.forename: M P
authors.initials: MP
authors.lastname: Mortimore
mesh_terms: D000241:Adenosine / Q000378:metabolism; D000244:Adenosine Diphosphate / Q000378:metabolism; D000249:Adenosine Monophosphate / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy; D003001:Cloning, Molecular; D000077144:Clopidogrel; D003550:Cystic Fibrosis / Q000188:drug therapy; D006801:Humans; D009883:Ophthalmic Solutions / Q000627:therapeutic use; D011122:Polyphosphates; D018048:Receptors, Purinergic P2 / Q000737:chemistry / Q000378:metabolism; D013329:Structure-Activity Relationship; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014018:Tissue Distribution; D014500:Uracil Nucleotides
chemical_list: D009883:Ophthalmic Solutions; D011122:Polyphosphates; D018048:Receptors, Purinergic P2; D014500:Uracil Nucleotides; D000249:Adenosine Monophosphate; D000244:Adenosine Diphosphate; C117446:cangrelor; C403315:diquafosol; D000255:Adenosine Triphosphate; D000077144:Clopidogrel; D000241:Adenosine; D013988:Ticlopidine